BOULDER, CO, BranchLab, an AI platform transforming how pharmaceutical companies commercialize therapies, announced a $26 million Series A financing.
BranchLab, an AI platform transforming how pharmaceutical companies commercialize therapies, announced a $26 million Series A financing. The round led by McKesson Ventures, with participation from FCA Venture Partners, Sanofi Ventures, and AIX Ventures. The round brings total funding to $35 million.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.